CoChat

Combined Lifestyle Modification and Metformin in Obese Patients with Polycystic Ovary Syndrome: A Randomized, Placebo-controlled, Double-blind Multicentre Study

Tang, Thomas, Glanville, Julie, Hayden, Catherine J., White, Davinia, Barth, Julian H., Balen, Adam H. · 2006 · Obstetrical & Gynecological Survey
Cited by 64

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

Metformin therapy reportedly benefits women with polycystic ovary syndrome (PCOS). Its effect is presumably based on lowering serum insulin levels. Metformin inhibits glucose production in the liver and also enhances insulin sensitivity at the cellular level. This prospective, randomized, double-blind, placebo-controlled study evaluated the effects of lifestyle change and metformin therapy in 143 women with PCOS who were oligomenorrheic or amenorrheic and had a body mass index (BMI) greater than 30 kg/m2. All patients received standard dietary advice and were placed on an individualized high-carbohydrate, low-fat diet. Metformin, given in a dose of 850 mg twice daily, was compared with placebo over 6 months. The 69 patients placed on metformin and the 74 given placebo had similar characteristics at baseline and had been infertile for similar periods. Menstrual cycles became significantly more frequent in both metformin-treated and placebo patients. The median improvement was one cycle per 6 months. Reductions in body weight and BMI were documented in both groups. None of these parameters differed significantly between the actively treated and placebo patients. In neither group did insulin sensitivity or lipid profiles change significantly. Patients given metformin had significant reductions in waist circumference and the free androgen index. On logistic regression analysis, considering metformin therapy, percentage of weight loss, initial BMI, and age, only the percentage weight loss correlated with improved menstrual function. There were 2 pregnancies in each group. In this trial, metformin did not enhance weight loss or menstrual frequency in obese patients with PCOS compared with placebo patients. Only weight loss during dietary management made menstruation more frequent.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/01.ogx.0000197800.07214.dc

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Cited by

See all 64

Metadata

Authors
Tang, T., Glanville, J., Hayden, C. J., White, D., Barth, J. H., & Balen, A. H.
Venue
Obstetrical & Gynecological Survey
Published
2006-02
Volume
61
Issue
2
Pages
108-109
ISSN
0029-7828 (ISSN-L)
OpenAlex
W1979153691
Cited by
64
References
17
FWCI
2.18
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Combined Lifestyle Modification and Metformin in Obese Patients with Polycystic Ovary Syndrome: A Randomized, Placebo-controlled, Double-blind Multicentre Study. https://app.cochat.ai/papers/10.1097/01.ogx.0000197800.07214.dc
The paper
Tang, T., Glanville, J., Hayden, C. J., White, D., Barth, J. H., & Balen, A. H. (2006). Combined Lifestyle Modification and Metformin in Obese Patients with Polycystic Ovary Syndrome: A Randomized, Placebo-controlled, Double-blind Multicentre Study. Obstetrical & Gynecological Survey. https://doi.org/10.1097/01.ogx.0000197800.07214.dc

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.